Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Leqvio symbols : NVSEF save search
New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting
Published: 2024-04-06 (Crawled : 20:20) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
| Email alert
Add to watchlist
leqvio novartis therapy show
Novartis presents new long-term Leqvio® (inclisiran) data demonstrating consistent efficacy and safety beyond six years
Published: 2023-08-28 (Crawled : 12:00) - globenewswire.com
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 1.06%
H: 0.06%
C: -0.51%
leqvio six beyond novartis
US FDA approves expanded indication for Novartis Leqvio® (inclisiran) to include treatment of adults with high LDL-C and who are at increased risk of heart disease
Published: 2023-07-10 (Crawled : 12:00) - biospace.com/
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 1.44%
H: 0.73%
C: 0.48%
leqvio fda disease treatment risk novartis heart
Alnylam Comments on FDA Approval of Leqvio®, the First siRNA (RNAi Therapeutic) Approved to Reduce LDL-C
Published: 2021-12-22 (Crawled : 23:00) - biospace.com/
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: -0.55%
H: 0.99%
C: 0.92%
ALNY | News | $145.16 -0.11% -0.19% 400K
|
Health Technology
|
| O: -5.24%
H: 2.44%
C: -0.93%
leqvio fda fda approval approval
FDA approves Novartis Leqvio® (inclisiran), first-in-class siRNA to lower cholesterol and keep it low with two doses a year
Published: 2021-12-22 (Crawled : 23:00) - biospace.com/
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: -0.55%
H: 0.99%
C: 0.92%
leqvio novartis fda cholesterol
Gainers vs Losers
| 60% | 40% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.